RinuaGene

RinuaGene Biotechnology Co., Ltd. is dedicated to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA). With deep technical reserves, pharmaceutical industry experience, and management expertise, the company pursues innovation as a long-term goal. In its early stages, it focuses on building a robust R&D platform and rapidly advancing a diversified product pipeline. Targeting the Chinese market, RinuaGene aims to establish strong international competitiveness through innovation, quality, and efficiency. The founding team consists of former senior executives from international pharmaceutical companies and professors from renowned research institutions. They possess solid technical expertise and strong execution capabilities spanning preclinical research, drug development, GMP production, bioinformatics, quality control, and regulatory affairs. With an average of over 15 years of experience in the pharmaceutical industry, the team represents one of the most experienced groups in China’s mRNA drug development field.